These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Policy on monitoring and reporting results. Louis TA; Bouffioux C; Tazaki H; Acosta-Otero A; Khoury S; Kopp J; Mazeman E; Obata K; Tagnon H; Wittes RE Prog Clin Biol Res; 1986; 221():33-48. PubMed ID: 3809187 [No Abstract] [Full Text] [Related]
4. Statistical analysis techniques and sample size determination for clinical trials of treatments for bladder cancer. Byar D; Kaihara S; Sylvester R; Freedman L; Hannigan J; Koiso K; Oohashi Y; Tsugawa R Prog Clin Biol Res; 1986; 221():49-64. PubMed ID: 3809188 [No Abstract] [Full Text] [Related]
5. Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization. Bassi PF; Volpe A; Racioppi M; D'Agostino D; Gardi M; Totaro A; Pinto F; Sacco E; Bongiovanni L Urol Int; 2009; 83(3):258-63. PubMed ID: 19829021 [TBL] [Abstract][Full Text] [Related]
6. BCG in the management of superficial bladder cancer. Robinson MR Prog Clin Biol Res; 1985; 185B():161-6. PubMed ID: 3898140 [No Abstract] [Full Text] [Related]
7. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa]. Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633 [No Abstract] [Full Text] [Related]
8. The results of treatment of 107 patients with carcinoma of the bladder. Donker PJ Arch Chir Neerl; 1967; 19(3):179-85. PubMed ID: 5212320 [No Abstract] [Full Text] [Related]
9. Current trends in bladder cancer treatment. Lamm DL; Allaway M Ann Chir Gynaecol; 2000; 89(3):234-41. PubMed ID: 11079794 [No Abstract] [Full Text] [Related]
13. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols. Prout GR; Kopp J Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644 [No Abstract] [Full Text] [Related]
15. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival. Kurth KH Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914 [No Abstract] [Full Text] [Related]
16. The management of locally recurrent invasive bladder cancer following radical cystectomy. Pisters LL; Westney L Semin Urol Oncol; 1996 May; 14(2):112-9. PubMed ID: 8734739 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
18. Bladder-sparing procedure as good as cystectomy for treating invasive bladder cancer. Rollins G Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):7-9. PubMed ID: 12553324 [No Abstract] [Full Text] [Related]